Jonathan Faison

@jfais20 · ranked 0 of 7 scored days

Unranked

Score

Rank · last 14 scored days

Streak: 0 days
Scored days: 7in the 30-day window
Active calls: 1

Return · last 30 days

Total

-4.8%

Last close

-0.3%

Win rate

Active calls · a call counts fully for 14 days, then fades out by day 42

RVMD·Long·day 8

counts fully until Sep 9 · fades out by Oct 7

Calls, newest first

Read as: Long ABVX · High confidence

3 scored days since →

Jonathan Faison@jfais20
$ABVX - Agree (for those who like it) in an ideal zone buying wise including technicals (below major moving averages, lower end of trading range post cancer scare)
4d agoview on X ↗media on X

tweeted Mon, Aug 31 · counted from Tue, Sep 1 close

Read as: Long BHVN · High confidence

4 scored days since →

Jonathan Faison@jfais20
$BHVN (L) From Weekly Recap
6d agoview on X ↗media on X

tweeted Sat, Aug 29 · counted from Mon, Aug 31 close

Read as: Long CGEM · High confidence

4 scored days since →

Jonathan Faison@jfais20
$CGEM (L) From today's trades
7d agoview on X ↗media on X

tweeted Fri, Aug 28 · counted from Mon, Aug 31 close

Read as: Exit XBI · Medium confidence

4 scored days since →

Jonathan Faison@jfais20
Agreed- but seeing a lot of people who are new to the sector coming in for quick $$ without the prior bio bear market for context $XBI Recipe for pain unless they slow down 🙌
7d agoview on X ↗media on X

tweeted Fri, Aug 28 · counted from Mon, Aug 31 close

Read as: Mentions XBI · Low confidence

4 scored days since →

Jonathan Faison@jfais20
$XBI - Resonates (from Options Plays channel this AM)
7d agoview on X ↗media on X

tweeted Fri, Aug 28 · counted from Mon, Aug 31 close

Read as: Long KZIA · High confidence

4 scored days since →

Jonathan Faison@jfais20
$KZIA with a " $TRIL -type" financing (raising almost as much $ as prior market cap) Bullish signal in terms of demand 🧐 Yesterday, shared 83% ORR in first six TNBC patients treated including one complete metabolic response (also responses in broad range of mets including
7d agoview on X ↗

tweeted Fri, Aug 28 · counted from Mon, Aug 31 close

Read as: Long MESO · High confidence

7 scored days since →

Jonathan Faison@jfais20
$MESO (L) Posted my Q2 call notes in Chat- another setup I see relatively little on elsewhere 1,100 patents/pending, IP to 2044 (long runway= high strategic value to acquirer) First-mover advantage (first and only mesenchymal stromal cell product approved by the FDA), complex
8d agoview on X ↗

tweeted Thu, Aug 27 · counted from Fri, Aug 28 close

Read as: Long RVMD · High confidence

7 scored days since →

Jonathan Faison@jfais20
Worth reiterating the obvious- THIS is what biotech is all about 👏 Nearly doubling survival vs chemo in previously treated PDAC after decades of failure Admittedly room to improve including side effect profile, BUT this is how progress takes place (one breakthrough at a time)
9d agoview on X ↗

tweeted Wed, Aug 26 · counted from Thu, Aug 27 close

Read as: Long RVMD · High confidence

7 scored days since →

tweeted Wed, Aug 26 · counted from Thu, Aug 27 close · view on X ↗

Read as: Mentions TENX · Low confidence

7 scored days since →

tweeted Tue, Aug 25 · counted from Wed, Aug 26 close · view on X ↗

Read as: Exit SLS · High confidence

7 scored days since →

tweeted Tue, Aug 25 · counted from Wed, Aug 26 close · view on X ↗

Read as: Long KURA · High confidence

7 scored days since →